4.7 Review

Ocular Vascular Diseases: From Retinal Immune Privilege to Inflammation

Journal

Publisher

MDPI
DOI: 10.3390/ijms241512090

Keywords

retina; immune privilege; inflammation; retinopathy of prematurity; age-related macular degeneration; diabetic retinopathy

Ask authors/readers for more resources

The eye has immune privilege to protect retinal neural cells from immune provocation. However, breach of this privilege can lead to acute inflammatory responses and chronic inflammation, causing ocular diseases and vision loss. This review discusses the features of immune privilege in the retina, the inflammatory responses and factors involved when immune privilege fails, as well as recent advances in ocular immunity and ocular vascular diseases.
The eye is an immune privileged tissue that insulates the visual system from local and systemic immune provocation to preserve homeostatic functions of highly specialized retinal neural cells. If immune privilege is breached, immune stimuli will invade the eye and subsequently trigger acute inflammatory responses. Local resident microglia become active and release numerous immunological factors to protect the integrity of retinal neural cells. Although acute inflammatory responses are necessary to control and eradicate insults to the eye, chronic inflammation can cause retinal tissue damage and cell dysfunction, leading to ocular disease and vision loss. In this review, we summarized features of immune privilege in the retina and the key inflammatory responses, factors, and intracellular pathways activated when retinal immune privilege fails, as well as a highlight of the recent clinical and research advances in ocular immunity and ocular vascular diseases including retinopathy of prematurity, age-related macular degeneration, and diabetic retinopathy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available